EA201791921A1 - Композиции для местного применения, содержащие кортикостероид - Google Patents

Композиции для местного применения, содержащие кортикостероид

Info

Publication number
EA201791921A1
EA201791921A1 EA201791921A EA201791921A EA201791921A1 EA 201791921 A1 EA201791921 A1 EA 201791921A1 EA 201791921 A EA201791921 A EA 201791921A EA 201791921 A EA201791921 A EA 201791921A EA 201791921 A1 EA201791921 A1 EA 201791921A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compositions
local application
application containing
containing corticosteroids
corticosteroids
Prior art date
Application number
EA201791921A
Other languages
English (en)
Other versions
EA037380B1 (ru
Inventor
Сатиш Кандавилли
Мадхусудхан Боммагани
Виджендра Наламотху
Франклин Окуму
Амалавоял Рагхав Чари
Original Assignee
Промиус Фарма Ллк
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Промиус Фарма Ллк filed Critical Промиус Фарма Ллк
Publication of EA201791921A1 publication Critical patent/EA201791921A1/ru
Publication of EA037380B1 publication Critical patent/EA037380B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Композиции для местного применения, содержащие кортикостероид и по меньшей мере один интенсификатор проникновения, при этом упомянутая композиция, по существу, не содержит пропиленгликоля.
EA201791921A 2014-03-11 2016-03-11 Композиция для местного применения, содержащая кортикостероид EA037380B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461951188P 2014-03-11 2014-03-11
US14/645,297 US20160184431A1 (en) 2014-03-11 2015-03-11 Topical compositions comprising a corticosteroid
PCT/US2016/022194 WO2016145407A1 (en) 2014-03-11 2016-03-11 Topical compositions comprising a corticosteroid

Publications (2)

Publication Number Publication Date
EA201791921A1 true EA201791921A1 (ru) 2018-03-30
EA037380B1 EA037380B1 (ru) 2021-03-22

Family

ID=56163000

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201791921A EA037380B1 (ru) 2014-03-11 2016-03-11 Композиция для местного применения, содержащая кортикостероид

Country Status (16)

Country Link
US (4) US20160184431A1 (ru)
EP (1) EP3267978B1 (ru)
JP (2) JP2018507891A (ru)
KR (2) KR20200051854A (ru)
CN (1) CN107872972A (ru)
AU (1) AU2016228574B2 (ru)
BR (1) BR112017019352B1 (ru)
CA (1) CA2979051C (ru)
CO (1) CO2017010091A2 (ru)
EA (1) EA037380B1 (ru)
ES (1) ES2861374T3 (ru)
MX (1) MX2017011521A (ru)
NZ (1) NZ735341A (ru)
RU (1) RU2690659C2 (ru)
UA (1) UA121232C2 (ru)
WO (1) WO2016145407A1 (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011026076A2 (en) 2009-08-31 2011-03-03 Dr. Reddy's Laboratories Ltd. Topical formulations comprising a steroid
US20160184431A1 (en) 2014-03-11 2016-06-30 Promius Pharma Llc Topical compositions comprising a corticosteroid
WO2018191601A1 (en) * 2017-04-13 2018-10-18 Odan Laboratories, Ltd. Stable pharmaceutical compositions comprising desonide
JP2022525221A (ja) 2019-03-14 2022-05-11 クレシタ セラピューティクス インコーポレイテッド 洗い流し組成物および活性剤を送達するためのそれらの使用
US20210069214A1 (en) * 2019-09-06 2021-03-11 Encore Dermatology, Inc. Topical compositions comprising a corticosteroid for the treatment of psoriasis in pediatric patients
EP4103151A1 (en) * 2020-02-11 2022-12-21 Taro Pharmaceutical Industries Ltd. Compositions comprising desoximetasone and tazarotene
CN114272203B (zh) * 2021-12-27 2023-09-26 福元药业有限公司 一种糠酸莫米松乳膏及其制备方法
WO2023172216A1 (en) * 2022-03-11 2023-09-14 Ilko Ilac Sanayi Ve Ticaret A.S. Hydrocortisone and pramoxine topical formulations having enhanced in-vitro release
WO2024005726A1 (en) * 2022-06-30 2024-01-04 Ilko Ilac Sanayi Ve Ticaret A.S. Storage stable topical composition comprising clobetasol

Family Cites Families (96)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3892856A (en) 1974-04-10 1975-07-01 Squibb & Sons Inc Topical steroid formulation
US3934013A (en) 1975-02-21 1976-01-20 Syntex (U.S.A.) Inc. Pharmaceutical composition
US4053089A (en) 1975-08-01 1977-10-11 Lever Brothers Company Pump for dispensing liquids
US4343798A (en) 1981-06-23 1982-08-10 The Procter & Gamble Company Topical antimicrobial anti-inflammatory compositions
US4552872A (en) 1983-06-21 1985-11-12 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing corticosteroids
WO1991008733A1 (en) 1989-12-20 1991-06-27 Schering Corporation Stable cream and lotion bases for lipophilic drug compositions
FR2656900B1 (fr) 1990-01-10 1994-01-28 Oreal Pompe manuelle a precompression pour la pulverisation d'un liquide, notamment d'un parfum.
US5068099A (en) 1990-01-16 1991-11-26 S. C. Johnson & Son, Inc. Hair spray package with low volatile organic compound emission
IT1247529B (it) 1991-04-24 1994-12-17 Poli Ind Chimica Spa Composizioni farmaceutiche in forma di schiuma per somministrazione intravaginale, cutanea e orale
WO1994013257A1 (en) 1992-12-16 1994-06-23 Creative Products Resource Associates, Ltd. Occlusive/semi-occlusive lotion for treatment of a skin disease or disorder
FR2715585B1 (fr) 1994-01-28 1996-03-08 Oreal Ensemble de distribution d'un liquide, de façon quasi-continue, comportant une pompe et utilisation d'un tel ensemble pour la pulvérisation d'une laque capillaire.
US5976555A (en) 1994-09-07 1999-11-02 Johnson & Johnson Consumer Products, Inc. Topical oil-in-water emulsions containing retinoids
ES2180599T3 (es) 1994-09-30 2003-02-16 Mika Pharma Ges Fur Die Entwic Composicion farmaceutica.
GB9504265D0 (en) 1995-03-03 1995-04-19 Medeva Plc Corticosteroid-containing pharmaceutical composition
ZA966579B (en) * 1995-08-04 1998-02-02 Wakamoto Pharma Co Ltd O/W emulsion composition for eye drops.
US6158617A (en) 1996-10-30 2000-12-12 The Procter & Gamble Company Concentrated reduced dosage spray pump delivery system
KR20010013377A (ko) 1997-06-04 2001-02-26 데이비드 엠 모이어 마일드한 잔류성 항균 조성물
US6075056A (en) 1997-10-03 2000-06-13 Penederm, Inc. Antifungal/steroid topical compositions
US5972920A (en) 1998-02-12 1999-10-26 Dermalogix Partners, Inc. Formulation containing a carrier, active ingredient, and surfactant for treating skin disorders
AUPP310798A0 (en) 1998-04-22 1998-05-14 Soltec Research Pty Ltd Vehicle system for a composition comprising a piperidinopyrimidine derivative
FR2761600B1 (fr) 1998-06-19 2000-03-31 Oreal Composition moussante pour le lavage et le traitement des cheveux et/ou du cuir chevelu a base d'un principe actif, d'un tensioactif anionique, d'un tensioactif amphotere et d'un agent propenetrant
US6284234B1 (en) 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents
US6670144B1 (en) 1999-02-26 2003-12-30 Cyclacel, Ltd. Compositions and methods for monitoring the phosphorylation of natural binding partners
US7393548B2 (en) 1999-03-22 2008-07-01 J.P. M.E.D. Ltd. Nano oil in glycerin emulsion
US6962691B1 (en) 1999-05-20 2005-11-08 U & I Pharmaceuticals Ltd. Topical spray compositions
US6656928B1 (en) 1999-09-02 2003-12-02 Mccadden Michael E. Composition for the topical treatment of rashes, dermatoses and lesions
US6479058B1 (en) 1999-09-02 2002-11-12 Mccadden Michael E. Composition for the topical treatment of poison ivy and other forms of contact dermatitis
US6432415B1 (en) 1999-12-17 2002-08-13 Axrix Laboratories, Inc. Pharmaceutical gel and aerosol formulations and methods to administer the same to skin and mucosal surfaces
US7029694B2 (en) 2000-04-26 2006-04-18 Watson Laboratories, Inc. Compositions and methods for transdermal oxybutynin therapy
US6387383B1 (en) 2000-08-03 2002-05-14 Dow Pharmaceutical Sciences Topical low-viscosity gel composition
US6579512B2 (en) 2001-06-15 2003-06-17 Crutchfield, Iii Charles E. Topical steroid spray
FR2830187B1 (fr) 2001-09-28 2004-10-15 Oreal Emulsion ultrafine contenant un derive haloalkynylique
IL161103A0 (en) * 2001-10-04 2004-08-31 Macrochem Corp Ibuprofen salt emulsifiers and cream formulations containing same
DE10154237A1 (de) 2001-11-07 2003-05-15 Steag Microparts Gmbh Zerstäuber für manuelle Betätigung
WO2003043657A1 (en) 2001-11-19 2003-05-30 Control Delivery Systems, Inc. Topical delivery of codrugs
US6765001B2 (en) 2001-12-21 2004-07-20 Medicis Pharmaceutical Corporation Compositions and methods for enhancing corticosteroid delivery
GB0217866D0 (en) 2002-08-01 2002-09-11 Steag Microparts Gmbh Low dose spray pump
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20060018937A1 (en) 2002-10-25 2006-01-26 Foamix Ltd. Steroid kit and foamable composition and uses thereof
US20080206161A1 (en) 2002-10-25 2008-08-28 Dov Tamarkin Quiescent foamable compositions, steroids, kits and uses thereof
DK1613346T3 (da) 2003-04-04 2013-01-07 Pah Usa 15 Llc Mikrofluidiske olie-i-vand-emulsioner og vaccinesammensætninger
FR2856301B1 (fr) 2003-06-23 2007-08-03 Galderma Res & Dev Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile
EP1663142A2 (en) 2003-06-23 2006-06-07 MacroChem Corporation Compositons and methods for topical administration
CL2004001884A1 (es) 2003-08-04 2005-06-03 Pfizer Prod Inc Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros.
GB0403702D0 (en) * 2004-02-19 2004-03-24 Boots Co Plc Skincare compositions
US20060099173A1 (en) 2003-10-24 2006-05-11 Nancy Puglia Topical skin care composition
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
JP2007533697A (ja) 2004-04-22 2007-11-22 デュオコート エービー グルココルチコイド救急治療用の医薬組成物
US20070189977A1 (en) 2004-06-07 2007-08-16 Jie Zhang Spray-on formulations and methods for dermal delivery of drugs
FR2871700B1 (fr) 2004-06-17 2006-11-17 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, et une phase huileuse
FR2871699A1 (fr) * 2004-06-17 2005-12-23 Galderma Sa Composition de type emulsion inverse contenant du calcitrol et du 17-propionate de clobetasol, et ses utilisations en cosmetiques et en dermatologie
FR2871697B1 (fr) * 2004-06-17 2007-06-29 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, au moins un silicone volatile et une phase huileuse non volatile
RU2381023C2 (ru) * 2004-08-31 2010-02-10 Стифель Ресёрч Австралия Пти Лтд Способ получения микроэмульсий и субмикронных эмульсий и композиции на их основе
US20080275014A1 (en) * 2004-12-08 2008-11-06 Galderma S.A. Clobetasol Propionate Shampoos for the Treatment of Seborrheic Dermatitis of the Scalp
EP1863434A4 (en) 2005-03-16 2012-03-07 Taro Pharmaceuticals Usa Inc STABLE AQUEOUS EMULSION FORMULATION COMPRISING UREA AND SALICYLIC ACID AND METHOD OF USE
US20060246098A1 (en) 2005-03-16 2006-11-02 Srinivasa Rao Stable aqueous-based emulsion formulation comprising urea and salicylic acid and method of using same
FR2884419B1 (fr) 2005-04-19 2007-06-22 Galderma Sa Composition de type solution filmogene comprenant de la vitamine d ou un de ses derives et un corticosteroide, et son utilisation en dermatologie
RU2397769C2 (ru) 2005-04-25 2010-08-27 Дау Фармасьютикал Сайенсиз Применение состава для распыления, содержащего клобетазол, для лечения псориаза
FR2889662B1 (fr) * 2005-08-11 2011-01-14 Galderma Res & Dev Emulsion de type huile-dans-eau pour application topique en dermatologie
KR20080055852A (ko) * 2005-08-31 2008-06-19 세렌티스 리미티드 스타필로코커스 아우레우스에 의한 콜로니화를 특징으로하는 염증성 피부 병태의 치료를 위한 아우레오리신억제제의 용도
FR2893845B1 (fr) 2005-11-30 2010-10-29 Galderma Sa Composition sous forme de spray comprenant un corticoide et une phase huileuse
US20070243132A1 (en) 2005-12-22 2007-10-18 Apollo Life Sciences Limited Transdermal delivery of pharmaceutical agents
WO2007079466A2 (en) 2006-01-04 2007-07-12 Nano Mist International, Llc Air driven delivery system for sprayable media
US20100278759A1 (en) 2006-02-08 2010-11-04 Howard Murad Topical Therapeutic Delivery System
KR101018819B1 (ko) 2006-02-14 2011-03-04 (주)아모레퍼시픽 티오우레아 유도체를 함유하는 소양성 또는 자극성피부질환의 예방 또는 치료용 외용제 조성물
WO2007103555A2 (en) 2006-03-08 2007-09-13 Nuviance, Inc. Transdermal drug delivery compositions and topical compositions for application on the skin
FR2898498B1 (fr) 2006-03-15 2008-11-28 Galderma Sa Nouvelles compositions topiques sous forme d'emulsion h/e comprenant un glycol pro-penetrant
FR2898499B1 (fr) 2006-03-15 2008-11-28 Galderma Sa Nouvelles compositions topiques sous forme d'emulsion h/e comprenant un glycol pro-penetrant
US20080003208A1 (en) 2006-05-11 2008-01-03 Avicena Froup, Inc. Creatine-ligand compounds and methods of use thereof
KR20090064440A (ko) 2006-09-08 2009-06-18 포믹스 리미티드 착색된 또는 착색 가능한 발포성 조성물 및 발포체
GB2443162B (en) 2006-10-28 2011-02-09 Nupharm Lab Ltd Betamethasone spray
WO2009007785A2 (en) 2006-11-14 2009-01-15 Foamix Ltd. Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
AU2007332800A1 (en) 2006-12-07 2008-06-19 Avicena Group, Inc. Creatine compositions for skin treatment
PT2173169E (pt) 2007-06-28 2014-09-03 Cydex Pharmaceuticals Inc Entrega nasal de soluções de corticosteróide aquosas
WO2009015456A1 (en) 2007-07-30 2009-02-05 Generex Pharmaceuticals Inc. Pharmaceutical formulation in mixed micellar form and dispenser for oral delivery of agents as a spray
JP2010535774A (ja) 2007-08-06 2010-11-25 インシス セラピューティクス インコーポレイテッド 経口カンナビノイド液体製剤および治療方法
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
RU2470645C2 (ru) 2007-09-10 2012-12-27 Гленмарк Фармасьютикалс Лимитед Фармацевтическая композиция для местного применения, содержащая комбинацию фузидовой кислоты и кортикостероида
AR068409A1 (es) 2007-09-14 2009-11-18 Drugtech Corp Composiciones farmaceuticas, transdermicas sin alcohol
US20090093547A1 (en) 2007-10-09 2009-04-09 Sciele Pharma, Inc. Compositions and Methods for Treating Premature Ejaculation
US20090130029A1 (en) 2007-11-21 2009-05-21 Foamix Ltd. Glycerol ethers vehicle and pharmaceutical compositions thereof
US20100249060A1 (en) * 2009-02-23 2010-09-30 Smith Jan G Topical formulation of low level clobetasol propionate for treating disorders of the skin and mucous membranes
US20120238535A1 (en) * 2009-02-23 2012-09-20 Smith Jan G Topical formulation of low level clobetasol propionate for treating disorders of the skin and mucous membranes
US10568859B2 (en) 2009-02-25 2020-02-25 Mayne Pharma Llc Topical foam composition
WO2011026076A2 (en) 2009-08-31 2011-03-03 Dr. Reddy's Laboratories Ltd. Topical formulations comprising a steroid
EP2482788B1 (en) 2009-10-02 2022-12-14 Journey Medical Corporation Topical tetracycline compositions
WO2011156030A2 (en) 2010-06-11 2011-12-15 Precision Dermatology, Inc. High oil-content emollient aerosol foam compositions
WO2012053007A1 (en) * 2010-10-21 2012-04-26 Cadila Healthcare Limited Topical pharmaceutical compositions containing nanodroplets for the treatment psoriasis
US8809307B2 (en) * 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
DK2704687T3 (en) 2011-05-04 2015-10-05 Chiesi Farma Spa Topical formulation having a corticosteroid as an active ingredient
CN102526070A (zh) 2012-01-04 2012-07-04 西北农林科技大学 一种复方联苯苄唑纳米乳喷剂及其制备方法
US10953021B2 (en) 2013-03-15 2021-03-23 Lupin Limited Topical compositions of flunisolide and methods of treatment
WO2014197398A1 (en) 2013-06-03 2014-12-11 Tolmar, Inc. Corticosteroid compositions
US10111956B2 (en) * 2013-06-03 2018-10-30 Tolmar, Inc. Corticosteroid compositions
ES2857602T3 (es) 2014-03-11 2021-09-29 Promius Pharma Llc Composiciones tópicas de corticosteroides
US20160184431A1 (en) 2014-03-11 2016-06-30 Promius Pharma Llc Topical compositions comprising a corticosteroid

Also Published As

Publication number Publication date
EA037380B1 (ru) 2021-03-22
CN107872972A (zh) 2018-04-03
MX2017011521A (es) 2018-01-11
US20160199493A1 (en) 2016-07-14
BR112017019352B1 (pt) 2023-12-19
RU2017134440A (ru) 2019-04-11
CA2979051A1 (en) 2016-09-15
KR20200051854A (ko) 2020-05-13
BR112017019352A2 (pt) 2018-06-05
EP3267978A1 (en) 2018-01-17
CA2979051C (en) 2019-09-17
US20190175735A1 (en) 2019-06-13
ES2861374T3 (es) 2021-10-06
EP3267978B1 (en) 2021-01-20
RU2690659C2 (ru) 2019-06-05
WO2016145407A1 (en) 2016-09-15
JP2018507891A (ja) 2018-03-22
US11179465B2 (en) 2021-11-23
AU2016228574A1 (en) 2017-09-28
KR20170123335A (ko) 2017-11-07
US20180078643A1 (en) 2018-03-22
UA121232C2 (uk) 2020-04-27
NZ735341A (en) 2019-05-31
US9855334B2 (en) 2018-01-02
US20160184431A1 (en) 2016-06-30
AU2016228574B2 (en) 2019-05-02
CO2017010091A2 (es) 2018-01-05
JP2021008505A (ja) 2021-01-28
RU2017134440A3 (ru) 2019-04-11

Similar Documents

Publication Publication Date Title
EA201791921A1 (ru) Композиции для местного применения, содержащие кортикостероид
IL273823A (en) Methods and preparations for local administration
MX2018012486A (es) Composiciones para aplicacion topica de compuestos.
CY1125205T1 (el) Φαρμακευτικες συνθεσεις δραστικων απο θεραπευτικη αποψη ενωσεων
IL273300A (en) High dose valbenazine formulation and related preparations, methods and kits
BR112017021665A2 (pt) composições de conservantes sinérgicos.
MX2017015990A (es) Composiciones topicas que comprenden un corticosteroide y un retinoide para tratar psoriasis.
ZA201606704B (en) Topical corticosteroid compositions
EA201591615A1 (ru) Замещенные ксантины и способы их применения
MX2019005833A (es) Administracion transdermica de agentes grandes.
BR112018002983A2 (pt) composição compreendendo uma lactama e um álcool
EA201790650A1 (ru) Лекарственная форма и способы применения абиратерона ацетата
CL2016003074A1 (es) Compuestos derivados de 2-oxi-2-fenil-n-5-pirrolidin-3-ilamino-1,3,4-tiadiazol-2-ilacetamida, inhibidores gls1 composición farmacéutica y su uso para tratar el cáncer.
BR112017001221A2 (pt) derivados de indolizina que são aplicáveis a doenças neurodegenerativas
EP3314636A4 (en) REDUCTION OF PARASITICAL LEAKAGE CURRENT IN THE DEACTIVE CONDITION FOR TUNNEL FIELD EFFECT TRANSISTORS
DOP2017000058A (es) Derivados de tetrahidroquinolina como inhibidores del bromodominio
CY1123408T1 (el) Φαρμακευτικες συνθεσεις και χρηση των αυτων
EA202190201A1 (ru) Составы для уменьшения размера опухоли и способы их применения
EA201791716A1 (ru) Фармацевтический состав
MX2018014790A (es) Formulacion combinada de tres compuestos antivirales.
BR112017004552A2 (pt) composições farmacêuticas
EP3332787A4 (en) Transdermally absorbable composition
EA201791483A1 (ru) Фармацевтическая композиция для лечения микоза
GB2543709A (en) Pharmaceutical agent
EP3322482A4 (en) TOPICAL CIPROFLOXACIN COMPOSITIONS